ask="0.7500"
ask_size="2000"
average_daily_volume="2005860"
bid="0.5800"
bid_size="700"
book_value="0.1800"
change="-0.0153"
change_from_200_day_moving_average="-1.2731"
change_from_50_day_moving_average="-0.0313"
change_from_52_week_high="-4.3104"
change_From_52_week_low="0.0796"
change_in_percent="-2.5293%"
close="0.5896"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.6080"
ebitda="-56.86M"
eps_estimate_current_year="-0.9600"
eps_estimate_next_quarter="-0.2400"
eps_estimate_next_year="-0.9000"
ex_dividend_date="N/A"
float_shares="41277000"
high="0.6144"
high_52_weeks="4.9000"
last_trade_date="3/7/2017"
last_trade_price="0.5896"
last_trade_size="9407"
last_trade_time="4:00pm"
low="0.5801"
low_52_weeks="0.5100"
market_capitalization="27.10M"
moving_average_200_day="1.8627"
moving_average_50_day="0.6209"
name="Anthera Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.8500"
open="0.6040"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-68.3474%"
percent_change_from_50_day_moving_average="-5.0345%"
percent_change_from_52_week_high="-87.9673%"
percent_change_from_52_week_low="+15.6079%"
previous_close="0.6049"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.3606"
price_per_sales="191.7505"
revenue="144999.00"
shares_outstanding="45964000"
short_ratio="4.1800"
stock_exchange="NGM"
symbol="ANTH"
volume="885712"
weeks_range_52="0.5100 - 4.9000"
